Barbara A. Hynd

987 total citations
25 papers, 871 citations indexed

About

Barbara A. Hynd is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Barbara A. Hynd has authored 25 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Barbara A. Hynd's work include Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipid metabolism and disorders (11 papers) and Cancer, Lipids, and Metabolism (4 papers). Barbara A. Hynd is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipid metabolism and disorders (11 papers) and Cancer, Lipids, and Metabolism (4 papers). Barbara A. Hynd collaborates with scholars based in United States and Finland. Barbara A. Hynd's co-authors include Moti L. Kashyap, Peter S. Gartside, Keijiro Saku, Kathleen G. Robinson, Laxmi Srivastava, Gladys Perisutti, Killian Robinson, Soaira G. Mendoza, Charles J. Glueck and Neil G. Almstead and has published in prestigious journals such as Journal of Clinical Investigation, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Barbara A. Hynd

25 papers receiving 809 citations

Peers

Barbara A. Hynd
Roger L. Barnhart United States
Peter Röschlau United States
L A Zech United States
Laurence Wong United States
P. Alaupovic United States
Richard S. Shulman United States
Roger L. Barnhart United States
Barbara A. Hynd
Citations per year, relative to Barbara A. Hynd Barbara A. Hynd (= 1×) peers Roger L. Barnhart

Countries citing papers authored by Barbara A. Hynd

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Hynd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Hynd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Hynd more than expected).

Fields of papers citing papers by Barbara A. Hynd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Hynd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Hynd. The network helps show where Barbara A. Hynd may publish in the future.

Co-authorship network of co-authors of Barbara A. Hynd

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Hynd. A scholar is included among the top collaborators of Barbara A. Hynd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Hynd. Barbara A. Hynd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pikul, Stanisław, Neil G. Almstead, Biswanath De, et al.. (2001). Heterocycle-based MMP Inhibitors with P2′ Substituents. Bioorganic & Medicinal Chemistry Letters. 11(8). 1009–1013. 38 indexed citations
2.
Almstead, Neil G., Stanisław Pikul, Biswanath De, et al.. (1999). Design, Synthesis, and Biological Evaluation of Potent Thiazine- and Thiazepine-Based Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry. 42(22). 4547–4562. 76 indexed citations
3.
Collins, Stephen M., et al.. (1997). High Throughput Autophosphorylation Assay for Bacterial Protein Histidine Kinases. SLAS DISCOVERY. 2(2). 85–90. 6 indexed citations
4.
Weisman, Steven M., et al.. (1994). Effects of Tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism. Inflammation Research. 41(3-4). 156–163. 14 indexed citations
5.
Nelson, Stephen L. & Barbara A. Hynd. (1993). ELISA kits measuring human IgG subclasses: cross-reactivity against IgG3 in an IgG1 ELISA. Clinical Chemistry. 39(9). 1919–1919. 1 indexed citations
6.
Nelson, Sandra L., et al.. (1992). Automated enzyme immunoassay to measure prostaglandin E2 in gingival crevicular fluid. Journal of Periodontal Research. 27(2). 143–148. 15 indexed citations
7.
Doyle, Matthew, Thomas H. Eichhold, Barbara A. Hynd, & Steven M. Weisman. (1990). Determination of leukotriene B4 in human plasma by gas chromatography using a mass selective detector and a stable isotope labelled internal standard. Effect of NE-11740 on arachidonic acid metabolism. Journal of Pharmaceutical and Biomedical Analysis. 8(2). 137–142. 14 indexed citations
8.
Saku, Keijiro, Soaira G. Mendoza, M. C. Laver, et al.. (1988). High-Density Lipoprotein Apolipoprotein AI and All Turnover in Moderate and Severe Proteinuria. ˜The œNephron journals/Nephron journals. 50(2). 112–115. 18 indexed citations
9.
Amoscato, Andrew A., George F. Babcock, R. Michael Sramkoski, Barbara A. Hynd, & Jan Alexander. (1987). Synthesis of two biologically active fluorescent probes of thymopentin. International journal of peptide & protein research. 29(2). 177–186. 6 indexed citations
10.
Babcock, George F., et al.. (1987). Flow cytometric analysis of lymphocyte subset phenotypes comparing normal children and adults.. PubMed. 5(4). 175–9. 37 indexed citations
11.
Saku, Keijiro, Peter S. Gartside, Barbara A. Hynd, Soaira G. Mendoza, & Moti L. Kashyap. (1985). Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia. Metabolism. 34(8). 754–764. 52 indexed citations
12.
Saku, Keijiro, Peter S. Gartside, Barbara A. Hynd, & Moti L. Kashyap. (1985). Mechanism of action of gemfibrozil on lipoprotein metabolism.. Journal of Clinical Investigation. 75(5). 1702–1712. 156 indexed citations
13.
Hynd, Barbara A., et al.. (1984). Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro. Biochemical and Biophysical Research Communications. 121(3). 946–952. 2 indexed citations
14.
Saku, Keijiro, et al.. (1984). C-II anapolipoproteinemia and severe hypertriglyceridemia. The American Journal of Medicine. 77(3). 457–462. 43 indexed citations
15.
Saku, Keijiro, G.S. Reddy, Barbara A. Hynd, & Moti L. Kashyap. (1984). Renal handling of high-density lipoproteins by isolated perfused kidneys. Metabolism. 33(5). 432–438. 18 indexed citations
16.
Kashyap, Moti L., Laxmi Srivastava, Barbara A. Hynd, Peter S. Gartside, & Gladys Perisutti. (1981). Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.. Journal of Lipid Research. 22(5). 800–810. 74 indexed citations
18.
Taskinen, Marja‐Riitta, Charles J. Glueck, Moti L. Kashyap, et al.. (1980). Post-heparin plasma lipoprotein and hepatic lipases. Atherosclerosis. 37(2). 247–256. 40 indexed citations
19.
Kashyap, Moti L., Laxmi Srivastava, Barbara A. Hynd, et al.. (1980). Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis. 35(1). 29–40. 43 indexed citations
20.
Kashyap, Moti L., Laxmi Srivastava, Barbara A. Hynd, et al.. (1978). The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism. Lipids. 13(12). 933–942. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026